Literature DB >> 33418796

Protein Nanoparticles: Promising Platforms for Drug Delivery Applications.

Annish Jain1, Sumit K Singh1, Shailendra K Arya1, Subhas C Kundu2, Sonia Kapoor1,3.   

Abstract

The development of drug delivery systems using nanoparticles as carriers for small and large therapeutic molecules remains a rapidly growing area of research. The advantages of using proteins to prepare nanoparticles for drug delivery applications include their abundance in natural sources, biocompatibility, biodegradability, easy synthesis process, and cost-effectiveness. In contrast to several particulate systems like nanoparticles from metallic and inorganic/synthetic sources, the protein nanoparticles do not have limitations such as potential toxicity, large size, accumulation, or rapid clearance from the body. In addition, protein-based nanoparticles offer the opportunity for surface modification by conjugation of other protein and carbohydrate ligands. This enables targeted delivery to the desired tissue and organ, which further reduces systemic toxicity. The use of protein nanoparticles for such applications could therefore prove to be a better alternative to maneuver and improve the pharmacokinetic and pharmacodynamic properties of the various types of drug molecules. In this review, while focusing on the properties of a few proteins such as the silk protein fibroin, we attempt to provide an overview of the existing protein-based nanoparticles. We discuss various methods for the synthesis of this class of nanoparticles. The review brings forth some of the factors that are important for the design of this class of nanoparticles and highlights the applications of the nanoparticles obtained from these proteins.

Entities:  

Keywords:  drug delivery; nanocarriers; nanoparticles; natural polymers; proteins

Year:  2018        PMID: 33418796     DOI: 10.1021/acsbiomaterials.8b01098

Source DB:  PubMed          Journal:  ACS Biomater Sci Eng        ISSN: 2373-9878


  27 in total

1.  Development of doxorubicin hydrochloride-loaded whey protein nanoparticles and its surface modification with N-acetyl cysteine for triple-negative breast cancer.

Authors:  Samipta Singh; Priyanka Maurya; Soniya Rani; Nidhi Mishra; Raquibun Nisha; Priya Singh; Shubhini A Saraf
Journal:  Drug Deliv Transl Res       Date:  2022-04-30       Impact factor: 4.617

Review 2.  Protein Nanoparticles: Uniting the Power of Proteins with Engineering Design Approaches.

Authors:  Nahal Habibi; Ava Mauser; Yeongun Ko; Joerg Lahann
Journal:  Adv Sci (Weinh)       Date:  2022-01-25       Impact factor: 16.806

Review 3.  Drug Delivery of Natural Products Through Nanocarriers for Effective Breast Cancer Therapy: A Comprehensive Review of Literature.

Authors:  Kah Min Yap; Mahendran Sekar; Shivkanya Fuloria; Yuan Seng Wu; Siew Hua Gan; Nur Najihah Izzati Mat Rani; Vetriselvan Subramaniyan; Chandrakant Kokare; Pei Teng Lum; M Yasmin Begum; Shankar Mani; Dhanalekshmi Unnikrishnan Meenakshi; Kathiresan V Sathasivam; Neeraj Kumar Fuloria
Journal:  Int J Nanomedicine       Date:  2021-12-02

4.  Tyrosine-Based Cross-Linking of Peptide Antigens to Generate Nanoclusters with Enhanced Immunogenicity: Demonstration Using the Conserved M2e Peptide of Influenza A.

Authors:  Logan R Wilks; Gaurav Joshi; Megan R Grisham; Harvinder Singh Gill
Journal:  ACS Infect Dis       Date:  2021-08-25       Impact factor: 5.578

Review 5.  Potentiating Therapeutic Effects of Epidermal Growth Factor Receptor Inhibition in Triple-Negative Breast Cancer.

Authors:  Kyu Sic You; Yong Weon Yi; Jeonghee Cho; Jeong-Soo Park; Yeon-Sun Seong
Journal:  Pharmaceuticals (Basel)       Date:  2021-06-18

Review 6.  A Critical Review of the Use of Surfactant-Coated Nanoparticles in Nanomedicine and Food Nanotechnology.

Authors:  Taiki Miyazawa; Mayuko Itaya; Gregor C Burdeos; Kiyotaka Nakagawa; Teruo Miyazawa
Journal:  Int J Nanomedicine       Date:  2021-06-09

Review 7.  Biocompatibility of nanomaterials and their immunological properties.

Authors:  Themis R Kyriakides; Arindam Raj; Tiffany H Tseng; Hugh Xiao; Ryan Nguyen; Farrah S Mohammed; Saiti Halder; Mengqing Xu; Michelle J Wu; Shuozhen Bao; Wendy C Sheu
Journal:  Biomed Mater       Date:  2021-03-11       Impact factor: 3.715

8.  Protein Based Biomaterials for Therapeutic and Diagnostic Applications.

Authors:  Stanley Chu; Andrew L Wang; Aparajita Bhattacharya; Jin Kim Montclare
Journal:  Prog Biomed Eng (Bristol)       Date:  2021-10-26

9.  Nanocages displaying SIRP gamma clusters combined with prophagocytic stimulus of phagocytes potentiate anti-tumor immunity.

Authors:  Yoonjeong Choi; Gi-Hoon Nam; Gi Beom Kim; Seohyun Kim; Yoon Kyoung Kim; Seong A Kim; Ha-Jeong Kim; Eun Jung Lee; In-San Kim
Journal:  Cancer Gene Ther       Date:  2021-08-04       Impact factor: 5.987

Review 10.  Flavonoid-Based Nanomedicines in Alzheimer's Disease Therapeutics: Promises Made, a Long Way To Go.

Authors:  Pragya Prasanna; Arun Upadhyay
Journal:  ACS Pharmacol Transl Sci       Date:  2021-01-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.